Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Vallet

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
European Journal of Clinical Investigation|November 2, 2024
Glycolytic activity following anti-CD19 CAR-T cell infusion in non-Hodgkin lymphomaNicolas Vallet, Laurianne Drieu Larochelle, Maria-Joao Santiago-Ribeiro, et al.
Haematologica|July 2, 2026
CPX-351 before allogeneic stem cell transplantation, a real-world French experienceEléonore Kaphan, Hélène Kemp, Nicolas Vallet, et al.
Annals of Hematology|January 8, 2020
Hypercalcemia is associated with a poor prognosis in lymphoma a retrospective monocentric matched-control study and extensive review of published reported casesNicolas Vallet, Marjan Ertault, Jean-Baptiste Delaye, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 21, 2026
Infectious events in fit patients with relapsed or refractory acute myeloid leukemia treated with azacitidine-venetoclax or intensive chemotherapyMaxime Bobo, Lucas Lefevre, Paul Mallet-Guy, et al.
Science Translational Medicine|February 23, 2022
Operational tolerance after hematopoietic stem cell transplantation is characterized by distinct transcriptional, phenotypic, and metabolic signaturesLaetitia Dubouchet, Helena Todorov, Ruth Seurinck, et al.
Cancers|November 27, 2021
Low-Dose Pesticides Alter Primary Human Bone Marrow Mesenchymal Stem/Stromal Cells through ALDH2 InhibitionAmélie Foucault, Noémie Ravalet, Joevin Besombes, et al.
Annals of Hematology|August 29, 2019
Characteristics, combinations, treatments, and survival of second primary hematological neoplasm: a retrospective single-center cohort of 49 patients (Hemo<sup>2</sup>study)Thomas Chalopin, Nicolas Vallet, Flavie Arbion, et al.
Hemasphere|February 14, 2025
HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantationSophie Le Grand, Juliette Villemonteix, Etienne Daguindau, et al.
Cell Host & Microbe|July 18, 2023
Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapsesNicolas Vallet, Maud Salmona, Jeanne Malet-Villemagne, et al.
The Journal of Clinical Investigation|August 29, 2024
Deciphering bone marrow engraftment after allogeneic stem cell transplantation in humans using single-cell analysesJennifer Bordenave, Dorota Gajda, David Michonneau, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
European Journal of Clinical Investigation|November 2, 2024
Glycolytic activity following anti-CD19 CAR-T cell infusion in non-Hodgkin lymphomaNicolas Vallet, Laurianne Drieu Larochelle, Maria-Joao Santiago-Ribeiro, et al.
Haematologica|July 2, 2026
CPX-351 before allogeneic stem cell transplantation, a real-world French experienceEléonore Kaphan, Hélène Kemp, Nicolas Vallet, et al.
Annals of Hematology|January 8, 2020
Hypercalcemia is associated with a poor prognosis in lymphoma a retrospective monocentric matched-control study and extensive review of published reported casesNicolas Vallet, Marjan Ertault, Jean-Baptiste Delaye, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 21, 2026
Infectious events in fit patients with relapsed or refractory acute myeloid leukemia treated with azacitidine-venetoclax or intensive chemotherapyMaxime Bobo, Lucas Lefevre, Paul Mallet-Guy, et al.
Science Translational Medicine|February 23, 2022
Operational tolerance after hematopoietic stem cell transplantation is characterized by distinct transcriptional, phenotypic, and metabolic signaturesLaetitia Dubouchet, Helena Todorov, Ruth Seurinck, et al.
Cancers|November 27, 2021
Low-Dose Pesticides Alter Primary Human Bone Marrow Mesenchymal Stem/Stromal Cells through ALDH2 InhibitionAmélie Foucault, Noémie Ravalet, Joevin Besombes, et al.
Annals of Hematology|August 29, 2019
Characteristics, combinations, treatments, and survival of second primary hematological neoplasm: a retrospective single-center cohort of 49 patients (Hemo<sup>2</sup>study)Thomas Chalopin, Nicolas Vallet, Flavie Arbion, et al.
Hemasphere|February 14, 2025
HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantationSophie Le Grand, Juliette Villemonteix, Etienne Daguindau, et al.
Cell Host & Microbe|July 18, 2023
Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapsesNicolas Vallet, Maud Salmona, Jeanne Malet-Villemagne, et al.
The Journal of Clinical Investigation|August 29, 2024
Deciphering bone marrow engraftment after allogeneic stem cell transplantation in humans using single-cell analysesJennifer Bordenave, Dorota Gajda, David Michonneau, et al.
Pageof 4